One of the greatest problems for pharmaceutical producers when it comes to GMP compliance is making certain the regularity of their batches – and this is particularly true when it comes to the manufacturing of supplements and pills. GMP consultants, both in the EU and USA, are likely to advise their customers on the arrival of a new variety of tablet coating which may well be advantageous in terms of guaranteeing the continuity of their manufacturing line – a crucial component when it comes to completing GMP and FDA auditing inspections.

Why GMP Consultants Are A Must In The Modern Era

Adhering with FDA and GMP guidelines is, for obvious reasons, essential and, in order to accomplish this goal, a large number of suppliers of pharmaceutical products will search for the assistance of GMP consultants. One of the most recent happenings in terms of providing compliance is the use of a tablet coating which can assist with producing a high level of batch to batch regularity. Chatting to GMP consultants about the most recent features on the marketplace is unquestionably one of the most successful means of helping ensure that auditing inspections are passed at the first try.

GMP compliance is something which is getting increasingly muddled due to the sheer number of rules that are continuously being imposed on the suppliers of pharmaceutical items. As a result of this, it is wise to consider the use of GMP consultants prior to FDA auditing because this will help paint a much clearer picture of exactly what needs to be carried out to help ensure the inspection is passed.

FDA and GMP training is something which is likely to provide considerable advantages in the long haul because it will help producers know what is asked of them in the course of auditing inspections but also has the potential to be a cost saver in terms of helping to reduce the probability of product recalls due to sub-standard or low quality pharmaceutical products.

When pharmaceutical companies decided to move the production if Active Pharmaceutical Ingredients (APIs) to Asia, they thought they would be getting a good deal on price. Production costs like labour and premises rent is better value than in the US. However, hidden costs in terms of logistics and communication are making this outsourcing more expensive than they expected.

Quality Issues
The US has been scrutinising the quality of Asian-produced drugs since the contaminated Heparin affair last year which saw death and serious illness across the nation. And we have seen a bigger demand for quality products made on American soil from consumers, healthcare professionals and the pharmaceutical companies. Quality is stringently measured by the FDA so GMP regulations have to be met by US based manufacturers.

Logistics
The logistics behind outsourcing part of the drug production to a country on the opposite side of the world are massive and expensive. And now the pharmaceutical companies are truly beginning to realise the true cost of this outsourcing. There are costs for employing solicitors, for hiring offices and for travel. These expenses on top of the other complications that are involved in oversees outsourcing can add up.

Communication Problems
When you outsource products overseas, communication is often the most complicated factor. It is hard to convey technical messages in foreign languages never mind everyday conversations. Manufacturers also need to factor in the time it takes for communication to occur between two different countries which are in a different time zone. You are putting your company at a poor position when you have to wait for time zones to align in order for you to be able to communicate with your suppliers abroad.

Now that the production of APIs has been outsourced to Asia for a number of years, the massive financial windfalls that companies expected have not proved to be realistic. GMP consultants are seeing that companies can make a bigger profit by guaranteeing their customers high quality drugs that comply with FDA and GMP regulations.